Neuropsychiatric disturbances in atypical Parkinsonian disorders

Daniele Belvisi, Isabella Berardelli, Antonio Suppa, Andrea Fabbrini, Massimo Pasquini, Maurizio Pompili, Giovanni Fabbrini

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system, and cognitive dysfunctions. In this paper, we reviewed the evidence available on the presence and type of neuropsychiatric disturbances in MSA, PSP, and CBD. A MedLine, Excerpta Medica, PsycLit, PsycInfo, and Index Medicus search was performed to identify all articles published on this topic between 1965 and 2018. Neuropsychiatric disturbances including depression, anxiety, agitation, and behavioral abnormalities have been frequently described in these disorders, with depression as the most frequent disturbance. MSA patients show a higher frequency of depressive disorders when compared to healthy controls. An increased frequency of anxiety disorders has also been reported in some patients, and no studies have investigated apathy. PSP patients may have depression, apathy, disinhibition, and to a lesser extent, anxiety and agitation. In CBD, neuropsychiatric disorders are similar to those present in PSP. Hallucinations and delusions are rarely reported in these disorders. Neuropsychiatric symptoms in MSA, PSP, and CBD do not appear to be related to the severity of motor dysfunction and are one of the main factors that determine a low quality of life. The results suggest that neuropsychiatric disturbances should always be assessed in patients with atypical parkinsonisms.

Original languageEnglish
Pages (from-to)2643-2656
Number of pages14
JournalNeuropsychiatric Disease and Treatment
Volume14
DOIs
Publication statusPublished - Oct 9 2018

Fingerprint

Progressive Supranuclear Palsy
Parkinsonian Disorders
Multiple System Atrophy
Apathy
Depression
Anxiety
Delusions
Hallucinations
Depressive Disorder
Anxiety Disorders
MEDLINE
Quality of Life

Keywords

  • Atypical parkinsonisms
  • Corticobasal degeneration
  • Depression
  • Multiple system atrophy
  • Neuropsychiatric disturbances
  • Progressive supranuclear palsy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Neuropsychiatric disturbances in atypical Parkinsonian disorders. / Belvisi, Daniele; Berardelli, Isabella; Suppa, Antonio; Fabbrini, Andrea; Pasquini, Massimo; Pompili, Maurizio; Fabbrini, Giovanni.

In: Neuropsychiatric Disease and Treatment, Vol. 14, 09.10.2018, p. 2643-2656.

Research output: Contribution to journalReview article

@article{beca2e4bee3348d3b8cb720b62f09103,
title = "Neuropsychiatric disturbances in atypical Parkinsonian disorders",
abstract = "Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system, and cognitive dysfunctions. In this paper, we reviewed the evidence available on the presence and type of neuropsychiatric disturbances in MSA, PSP, and CBD. A MedLine, Excerpta Medica, PsycLit, PsycInfo, and Index Medicus search was performed to identify all articles published on this topic between 1965 and 2018. Neuropsychiatric disturbances including depression, anxiety, agitation, and behavioral abnormalities have been frequently described in these disorders, with depression as the most frequent disturbance. MSA patients show a higher frequency of depressive disorders when compared to healthy controls. An increased frequency of anxiety disorders has also been reported in some patients, and no studies have investigated apathy. PSP patients may have depression, apathy, disinhibition, and to a lesser extent, anxiety and agitation. In CBD, neuropsychiatric disorders are similar to those present in PSP. Hallucinations and delusions are rarely reported in these disorders. Neuropsychiatric symptoms in MSA, PSP, and CBD do not appear to be related to the severity of motor dysfunction and are one of the main factors that determine a low quality of life. The results suggest that neuropsychiatric disturbances should always be assessed in patients with atypical parkinsonisms.",
keywords = "Atypical parkinsonisms, Corticobasal degeneration, Depression, Multiple system atrophy, Neuropsychiatric disturbances, Progressive supranuclear palsy",
author = "Daniele Belvisi and Isabella Berardelli and Antonio Suppa and Andrea Fabbrini and Massimo Pasquini and Maurizio Pompili and Giovanni Fabbrini",
year = "2018",
month = "10",
day = "9",
doi = "10.2147/NDT.S178263",
language = "English",
volume = "14",
pages = "2643--2656",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Neuropsychiatric disturbances in atypical Parkinsonian disorders

AU - Belvisi, Daniele

AU - Berardelli, Isabella

AU - Suppa, Antonio

AU - Fabbrini, Andrea

AU - Pasquini, Massimo

AU - Pompili, Maurizio

AU - Fabbrini, Giovanni

PY - 2018/10/9

Y1 - 2018/10/9

N2 - Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system, and cognitive dysfunctions. In this paper, we reviewed the evidence available on the presence and type of neuropsychiatric disturbances in MSA, PSP, and CBD. A MedLine, Excerpta Medica, PsycLit, PsycInfo, and Index Medicus search was performed to identify all articles published on this topic between 1965 and 2018. Neuropsychiatric disturbances including depression, anxiety, agitation, and behavioral abnormalities have been frequently described in these disorders, with depression as the most frequent disturbance. MSA patients show a higher frequency of depressive disorders when compared to healthy controls. An increased frequency of anxiety disorders has also been reported in some patients, and no studies have investigated apathy. PSP patients may have depression, apathy, disinhibition, and to a lesser extent, anxiety and agitation. In CBD, neuropsychiatric disorders are similar to those present in PSP. Hallucinations and delusions are rarely reported in these disorders. Neuropsychiatric symptoms in MSA, PSP, and CBD do not appear to be related to the severity of motor dysfunction and are one of the main factors that determine a low quality of life. The results suggest that neuropsychiatric disturbances should always be assessed in patients with atypical parkinsonisms.

AB - Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system, and cognitive dysfunctions. In this paper, we reviewed the evidence available on the presence and type of neuropsychiatric disturbances in MSA, PSP, and CBD. A MedLine, Excerpta Medica, PsycLit, PsycInfo, and Index Medicus search was performed to identify all articles published on this topic between 1965 and 2018. Neuropsychiatric disturbances including depression, anxiety, agitation, and behavioral abnormalities have been frequently described in these disorders, with depression as the most frequent disturbance. MSA patients show a higher frequency of depressive disorders when compared to healthy controls. An increased frequency of anxiety disorders has also been reported in some patients, and no studies have investigated apathy. PSP patients may have depression, apathy, disinhibition, and to a lesser extent, anxiety and agitation. In CBD, neuropsychiatric disorders are similar to those present in PSP. Hallucinations and delusions are rarely reported in these disorders. Neuropsychiatric symptoms in MSA, PSP, and CBD do not appear to be related to the severity of motor dysfunction and are one of the main factors that determine a low quality of life. The results suggest that neuropsychiatric disturbances should always be assessed in patients with atypical parkinsonisms.

KW - Atypical parkinsonisms

KW - Corticobasal degeneration

KW - Depression

KW - Multiple system atrophy

KW - Neuropsychiatric disturbances

KW - Progressive supranuclear palsy

UR - http://www.scopus.com/inward/record.url?scp=85057533396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057533396&partnerID=8YFLogxK

U2 - 10.2147/NDT.S178263

DO - 10.2147/NDT.S178263

M3 - Review article

AN - SCOPUS:85057533396

VL - 14

SP - 2643

EP - 2656

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -